...
首页> 外文期刊>Bioorganic and medicinal chemistry >Search for new pharmacophores for antimalarial activity. Part II: synthesis and antimalarial activity of new 6-ureido-4-anilinoquinazolines.
【24h】

Search for new pharmacophores for antimalarial activity. Part II: synthesis and antimalarial activity of new 6-ureido-4-anilinoquinazolines.

机译:寻找新的抗疟疾药效团。第二部分:新的6-ureido-4-anilinoquinazolines的合成和抗疟活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Synthesis of new 6-ureido-4-anilinoquinazolines have been accomplished and their in vitro antimalarial activity against chloroquine-sensitive P. falciparum have been examined. Out of 64 compounds evaluated, the IC(50) of 16 compounds which have displayed MIC of 0.25 microg/mL were also recorded. One of the compounds (24 g) had IC(50) value of 2.27 ng/mL which was equipotent to the standard drug chloroquine used in the bioassay. The in vivo evaluation of a few compounds among the series led to discovery of one analog (30 g) displaying 40% curative activity (28 days) against mdr P. yoeillinigeriensis at an oral dose of 100 mg/kg x 4 days.
机译:已经完成了新的6-脲基-4-苯胺基喹唑啉的合成,并且已经研究了它们对氯喹敏感的恶性疟原虫的体外抗疟活性。在评估的64种化合物中,还记录了16种化合物的IC(50),这些化合物的MIC为0.25微克/毫升。其中一种化合物(24 g)的IC(50)值为2.27 ng / mL,与生物测定中使用的标准药物氯喹等效。该系列中几种化合物的体内评估导致发现一种类似物(30 g),在口服剂量为100 mg / kg x 4天时,对mdr yoeillinigeriensis具有40%的治疗活性(28天)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号